Christensen IJ - Search Results

1

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma.

Holst CB, Christensen IJ, Vitting-Seerup K, Skjøth-Rasmussen J, Hamerlik P, Poulsen HS, Johansen JS. Holst CB, et al. Among authors: christensen ij. Neurooncol Adv. 2021 Jun 1;3(1):vdab072. doi: 10.1093/noajnl/vdab072. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34286278 Free PMC article.

2

The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays.

Andersen J, Thorpe SM, King WJ, Rose C, Christensen I, Rasmussen BB, Poulsen HS. Andersen J, et al. Eur J Cancer. 1990 Apr;26(4):442-9. doi: 10.1016/0277-5379(90)90013-j. Eur J Cancer. 1990. PMID: 1694085

3

Estrogen receptor in primary breast cancer estimated in paraffin-embedded tissue. A study of its usefulness compared to dextran-coated charcoal assay.

Andersen J, Thorpe SM, Rose C, Christensen I, Rasmussen BB, Poulsen HS. Andersen J, et al. Acta Oncol. 1991;30(6):685-90. doi: 10.3109/02841869109092440. Acta Oncol. 1991. PMID: 1958387

4

Serum YKL-40 and colorectal cancer.

Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. Cintin C, et al. Among authors: christensen ij. Br J Cancer. 1999 Mar;79(9-10):1494-9. doi: 10.1038/sj.bjc.6690238. Br J Cancer. 1999. PMID: 10188896 Free PMC article.

5

High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.

Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. Cintin C, et al. Among authors: christensen ij. Cancer. 2002 Jul 15;95(2):267-74. doi: 10.1002/cncr.10644. Cancer. 2002. PMID: 12124825 Free article.

6

High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.

Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brünner N, Harris AL. Johansen JS, et al. Among authors: christensen ij. Breast Cancer Res Treat. 2003 Jul;80(1):15-21. doi: 10.1023/A:1024431000710. Breast Cancer Res Treat. 2003. PMID: 12889595

7

High serum YKL-40 level in patients with small cell lung cancer is related to early death.

Johansen JS, Drivsholm L, Price PA, Christensen IJ. Johansen JS, et al. Among authors: christensen ij. Lung Cancer. 2004 Dec;46(3):333-40. doi: 10.1016/j.lungcan.2004.05.010. Lung Cancer. 2004. PMID: 15541818

8

Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma.

Brasso K, Christensen IJ, Johansen JS, Teisner B, Garnero P, Price PA, Iversen P. Brasso K, et al. Among authors: christensen ij. Prostate. 2006 Apr 1;66(5):503-13. doi: 10.1002/pros.20311. Prostate. 2006. PMID: 16372331 Clinical Trial.

9

Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma.

Schmidt H, Johansen JS, Sjoegren P, Christensen IJ, Sorensen BS, Fode K, Larsen J, von der Maase H. Schmidt H, et al. Among authors: christensen ij. J Clin Oncol. 2006 Feb 10;24(5):798-804. doi: 10.1200/JCO.2005.03.7960. Epub 2006 Jan 3. J Clin Oncol. 2006. PMID: 16391295

10

Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA 125).

Gronlund B, Høgdall EV, Christensen IJ, Johansen JS, Nørgaard-Pedersen B, Engelholm SA, Høgdall C. Gronlund B, et al. Among authors: christensen ij. Int J Biol Markers. 2006 Jul-Sep;21(3):141-8. doi: 10.1177/172460080602100302. Int J Biol Markers. 2006. PMID: 17013795 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

451 results

Search Page